Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
0 hedge funds and large institutions have $0 invested in Renalytix plc American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $2.63K → $0 (-$2.63K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIC
Ironwood Investment Counsel
Scottsdale,
Arizona
|
-$2.63K |
RNLX Hedge Fund Activity: Q4 2025 in Review
0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q4 2025, worth a combined $0 — down 100% from $2.63K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RNLX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Ironwood Investment Counsel, exiting entirely with an estimated $2.63K sold.
- 0 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q4 2025, down from 1 in Q3 2025.
- Funds reported $0 of Renalytix plc American Depositary Shares stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Renalytix plc American Depositary Shares positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Renalytix plc American Depositary Shares seller in Q4 2025 was Ironwood Investment Counsel, an estimated $2.63K sold.
Based on aggregated 13F filings for Q4 2025.